Catalyst Wire Dossier Catalyst Wire Dossier

QVA

indacaterol/glycopyrronium · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QVA, covering 2016-05-16 to 2016-05-16. Get the full timeline:

Most recent: Clinical Trial Update: QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations) [Phase 3]

See pricing